HSV-1 gB Antibodies

Santa Cruz Biotechnology features a diverse variety of HSV-1 gB monoclonal antibodies for research focused on understanding glycoprotein B in herpes simplex virus type 1. HSV-1 gB Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycoprotein B serves as a critical component of the HSV-1 envelope, playing a vital role in viral entry and fusion with host cells. The function of glycoprotein B is essential for viral infection and propagation within the host, making it a significant target for therapeutic interventions and vaccine development. Research focused on glycoprotein B mechanisms can provide insights into viral pathogenesis and potential strategies for controlling HSV-1 infections. Advanced research techniques and protocols enable detailed investigation of glycoprotein B's structural characteristics and functional properties. Multiple validation methods ensure reliable and reproducible results across different experimental conditions. Ongoing studies of glycoprotein B continue to reveal new aspects of HSV-1 biology and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of HSV-1 and developing innovative therapeutic strategies.